NCT05825898
Outcome of Patients With Severe Functional TR According to Medical, Transcatheter or Surgical Treatment
Enrolling by Invitation
Not specifiedAges 18+ObservationalOttawa Heart Institute Research CorporationInvestigator-initiated
~3,500 participants
Updated 2026-05-08 on ClinicalTrials.gov
What's tested:Surgery or Transcatheter tricuspid valve intervention
At a glance
Recruiting sites
0 of 44 listed sites are recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Survival at 2 years
Measured over 2 years
Conditions
Where it's being run
44 sites across 12 statesFrance12
Germany11
Spain5
New York3
Canada3
Switzerland3
Italy2
Minnesota1
Study leadership
- David Messika-Zeitoun · PRINCIPAL_INVESTIGATOR · Ottawa Heart Institute Research Corporation
Who to contact
This trial hasn't published a contact. View it on ClinicalTrials.gov
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Eligibility criteria
Inclusion
Age ≥ 18 years
Isolated (no left-valvular heart disease (mitral regurgitation) \>2)
AND Functional
AND Moderate to severe or severe Tricuspid regurgitation
Exclusion
Congenital valvular disease,
Previous tricuspid valve intervention,
Organic tricuspid valvular disease
Associated valvular heart disease
What this trial measures
- Survival at 2 years2 years
Mortality